Cwm LLC Has $2.55 Million Stock Position in Bath & Body Works, Inc. $BBWI

Key Points

• Cwm LLC increased its stake in Bath & Body Works, Inc. by 14.6%, owning a total of 85,192 shares valued at approximately $2.55 million.
• Bath & Body Works reported $1.55 billion in revenue for the last quarter, with an earnings per share (EPS) of $0.37, meeting analyst expectations.
• The company declared a quarterly dividend of $0.20 per share, representing an annualized dividend of $0.80 and a dividend yield of 3.0%.

Cwm LLC increased its stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 14.6% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 85,192 shares of the company's stock after acquiring an additional 10,861 shares during the quarter. Cwm LLC's holdings in Bath & Body Works were worth $2,552,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Stonehage Fleming Financial Services Holdings Ltd bought a new stake in Bath & Body Works in the second quarter worth approximately $33,000. SVB Wealth LLC bought a new stake in Bath & Body Works in the first quarter worth approximately $35,000. Geneos Wealth Management Inc. increased its holdings in Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company's stock worth $35,000 after purchasing an additional 801 shares in the last quarter. Parallel Advisors LLC increased its holdings in Bath & Body Works by 63.3% in the second quarter. Parallel Advisors LLC now owns 1,241 shares of the company's stock worth $37,000 after purchasing an additional 481 shares in the last quarter. Finally, Golden State Wealth Management LLC increased its holdings in Bath & Body Works by 94.7% in the first quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock worth $40,000 after purchasing an additional 642 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors.

Bath & Body Works Trading Up 1.9%

BBWI stock opened at $26.50 on Friday. The stock's fifty day simple moving average is $27.73 and its two-hundred day simple moving average is $29.10. Bath & Body Works, Inc. has a 1-year low of $24.85 and a 1-year high of $41.87. The stock has a market cap of $5.46 billion, a P/E ratio of 7.86, a P/E/G ratio of 0.91 and a beta of 1.52.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, hitting the consensus estimate of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The business had revenue of $1.55 billion for the quarter, compared to analysts' expectations of $1.55 billion. During the same quarter in the previous year, the firm earned $0.37 earnings per share. The business's revenue was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, September 5th. Stockholders of record on Friday, August 22nd were given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.0%. The ex-dividend date of this dividend was Friday, August 22nd. Bath & Body Works's dividend payout ratio is currently 23.74%.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on BBWI. Morgan Stanley lowered their target price on Bath & Body Works from $19.00 to $18.00 and set an "overweight" rating for the company in a report on Friday, September 12th. Citigroup decreased their price objective on Bath & Body Works from $42.00 to $40.00 and set a "buy" rating for the company in a report on Tuesday, August 19th. Telsey Advisory Group restated an "outperform" rating and set a $38.00 price objective on shares of Bath & Body Works in a report on Thursday, August 28th. UBS Group decreased their price objective on Bath & Body Works from $36.00 to $32.00 and set a "neutral" rating for the company in a report on Friday, August 29th. Finally, Weiss Ratings restated a "hold (c-)" rating on shares of Bath & Body Works in a report on Wednesday, October 8th. Eleven research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, Bath & Body Works presently has a consensus rating of "Moderate Buy" and an average price target of $37.46.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.